ArticleScientific reports2026
Synthesis of rare earth doped MoS
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The synthesis of Er- and Nd-doped MoS2 powders by the co-pyrolysis of molecular precursors is demonstrated by heating tetrakis-(diethyldithiocarbamato) molybdenum(IV) (Mo(DTC)4) and mono-1,10-phenanthroline tris-(diethyl dithiocarbamato) erbium(III) or mono-1,10-phenanthroline tris-(diethyl dithiocarbamato) neodymium(III) (Ln(DTC)3phen, where Ln = Er, Nd) to 500 °C for 1 h. Powder x-ray diffraction and Raman spectroscopy indicated that the resulting powders produced from this reaction are comprised of 0D nanoscale crystallites of the 2 H phase of MoS2. Spatial mapping of elements in these samples was performed in the scanning electron microscope at the microscale using energy dispersive X-ray spectroscopic mapping, which showed that the dopants are homogeneously distributed throughout the samples. Synchrotron radiation x-ray absorption measurements tentatively indicate that the dopants are incorporated within the MoS2 layers rather than being intercalated between them. Electron paramagnetic resonance spectroscopy and SQUID magnetometry demonstrated that rare earth doping of MoS2 significantly enhances the magnetic response of the material. Remarkably, the samples are found to remain paramagnetic down to temperature at least as low as 2 K.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.